POINT BIOPHARMA GLOBAL INC shareholders Q2 2023

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 131 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2023. The put-call ratio across all filers is 128.31 and the average weighting 0.2%.

POINT BIOPHARMA GLOBAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
Rafferty Asset Management, LLC 195,644$1,772,5350.01%
Clear Harbor Asset Management, LLC 10,000$90,6000.01%
BLAIR WILLIAM & CO/IL 265,530$2,405,7020.01%
E Fund Management Co., Ltd. 10,524$950.01%
Cubist Systematic Strategies, LLC 135,120$1,224,1920.01%
TUDOR INVESTMENT CORP ET AL 52,742$477,8430.01%
ALPS ADVISORS INC 80,186$726,4850.01%
Graham Capital Management, L.P. 19,533$176,9680.01%
Citadel Advisors 2,454,973$22,242,0550.01%
TWO SIGMA ADVISERS, LP 162,700$1,474,0620.00%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 243,165$2,2030.00%
MetLife Investment Management, LLC 46,389$420,2840.00%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 59,659$540,5110.00%
AMERICAN CENTURY COMPANIES INC 378,605$3,430,1610.00%
STRS OHIO 71,000$6430.00%
Nuveen Asset Management, LLC 1,107,766$10,036,3600.00%
SCOTIA CAPITAL INC. 50,000$453,0000.00%
EXCHANGE TRADED CONCEPTS, LLC 14,102$127,7640.00%
Gotham Asset Management, LLC 15,484$140,2850.00%
JANUS HENDERSON GROUP PLC 291,716$2,642,6570.00%
External links

This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q2 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.